Literature DB >> 19959698

Smoking cessation and relapse during a lung cancer screening program.

Christy M Anderson1, Rowena Yip, Claudia I Henschke, David F Yankelevitz, Jamie S Ostroff, David M Burns.   

Abstract

BACKGROUND: The potential for negative screening to reduce smoking cessation and long-term abstinence is a concern in lung cancer screening. We examine whether consistently negative results during long-term participation in a lung cancer screening program reduce cessation or increase relapse.
METHODS: Participants (N = 2,078) in the Early Lung Cancer Action Program received annual screenings and periodic smoking behavior surveys over a follow-up period as long as 12 years. Point abstinence and prolonged abstinence were examined among 730 baseline smokers. Relapse was examined among 1,227 former smokers who quit for 1 year or more at enrollment, 121 recent quitters at enrollment, and 155 baseline smokers who quit during follow-up. Abstinence and relapse for participants with consistently negative computerized tomography scan results were compared with those with non-cancer-positive results using stratified Cox models.
RESULTS: Baseline smokers with negative computerized tomography scans had a 28% lower likelihood of achieving point abstinence at one or more follow-up assessments compared with those with positive scans (hazard ratio, 0.72; P < 0.0004), but consistently negative scans were not associated with a lower likelihood of prolonged abstinence. A consistently negative scan was not associated with a higher likelihood of relapse back to smoking for long-term former smokers, recent quitters, or those who quit during follow-up.
CONCLUSIONS: We did not detect a lower long-term smoking abstinence or increased relapse over a 6-year period of follow-up among individuals participating in a lung cancer screening program who have a consistently negative screening compared with those with a positive, but noncancer, screening result.

Entities:  

Mesh:

Year:  2009        PMID: 19959698     DOI: 10.1158/1055-9965.EPI-09-0176

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  34 in total

1.  Effect of smoking cessation counseling within a randomised study on early detection of lung cancer in Germany.

Authors:  M Bade; V Bähr; U Brandt; A Eigentopf; T Brüchert; M-L Gross; E Motsch; N Becker
Journal:  J Cancer Res Clin Oncol       Date:  2016-01-27       Impact factor: 4.553

2.  A qualitative study of lung cancer risk perceptions and smoking beliefs among national lung screening trial participants.

Authors:  Elyse R Park; Joanna M Streck; Ilana F Gareen; Jamie S Ostroff; Kelly A Hyland; Nancy A Rigotti; Hannah Pajolek; Mark Nichter
Journal:  Nicotine Tob Res       Date:  2013-09-02       Impact factor: 4.244

Review 3.  Pairing smoking-cessation services with lung cancer screening: A clinical guideline from the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco.

Authors:  Lisa M Fucito; Sharon Czabafy; Peter S Hendricks; Chris Kotsen; Donna Richardson; Benjamin A Toll
Journal:  Cancer       Date:  2016-02-24       Impact factor: 6.860

4.  Tobacco Dependence Predicts Higher Lung Cancer and Mortality Rates and Lower Rates of Smoking Cessation in the National Lung Screening Trial.

Authors:  Alana M Rojewski; Nichole T Tanner; Lin Dai; James G Ravenel; Mulugeta Gebregziabher; Gerard A Silvestri; Benjamin A Toll
Journal:  Chest       Date:  2018-05-21       Impact factor: 9.410

5.  The Relations Between False Positive and Negative Screens and Smoking Cessation and Relapse in the National Lung Screening Trial: Implications for Public Health.

Authors:  Melissa A Clark; Jeremy J Gorelick; JoRean D Sicks; Elyse R Park; Amanda L Graham; David B Abrams; Ilana F Gareen
Journal:  Nicotine Tob Res       Date:  2015-03-06       Impact factor: 4.244

6.  Capitalizing on a teachable moment: Development of a targeted self-help smoking cessation intervention for patients receiving lung cancer screening.

Authors:  Lauren R Meltzer; Marina Unrod; Vani N Simmons; Karen O Brandon; Bárbara Piñeiro; Amanda M Palmer; Thomas H Brandon
Journal:  Lung Cancer       Date:  2019-02-18       Impact factor: 5.705

7.  Predictors of adverse smoking outcomes in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

Authors:  Samantha A Barry; Martin C Tammemagi; Sofiya Penek; Elisabeth C Kassan; Caroline S Dorfman; Thomas L Riley; John Commin; Kathryn L Taylor
Journal:  J Natl Cancer Inst       Date:  2012-10-26       Impact factor: 13.506

8.  Stages of change, determinants, and mortality for smoking cessation in adult Taiwanese screenees.

Authors:  Dih-Ling Luh; Hsiu-Hsi Chen; Long-Ren Liao; Sam Li-Sheng Chen; Amy Ming-Fang Yen; Ting-Ting Wang; Sherry Yueh-Hsia Chiu; Ching-Yuan Fann
Journal:  Prev Sci       Date:  2015-02

9.  Impact of lung cancer screening results on smoking cessation.

Authors:  Martin C Tammemägi; Christine D Berg; Thomas L Riley; Christopher R Cunningham; Kathryn L Taylor
Journal:  J Natl Cancer Inst       Date:  2014-05-28       Impact factor: 13.506

Review 10.  The importance of the regimen of screening in maximizing the benefit and minimizing the harms.

Authors:  Claudia I Henschke; Kunwei Li; Rowena Yip; Mary Salvatore; David F Yankelevitz
Journal:  Ann Transl Med       Date:  2016-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.